Font Size:
a
A
A
Keyword [Glucagon like peptide-1 receptor]
Result: 21 - 40 | Page: 2 of 3
21.
Protective Effect And Mechanism Of GLP-1 Receptor On Pulmonary Vascular Endothelial Cells In Acute Lung Injury
22.
Effects Of Glucagon-like Peptide-1 Receptor Agonists On Brain-derived Neurofactors In Patients With Type 2 Diabetes Mellitus
23.
Study On The Influencing Factors Of Gastrointestinal Adverse Reactions Induced By Glucagon-like Peptide-1 Receptor Agonists
24.
Effect Of Angiotensin ? Type 1 Receptor And Glucagon-like Peptide 1 Receptor Intracellular Phosphorylation Code On Its Function
25.
A Comparative Study Of The Effects Of Sioglitine And Liralutide On Early Lesions Of DKD
26.
Clinical Study On GLP-1RA Treatment Of Early Renal Injury In Obese Type 2 Diabetes Mellitus
27.
Effect Of Glucagon-like Peptide-1 Receptor Agonist On Carotid Atherosclerosis In Patients With Type 2 Diabetes Mellitus
28.
Efficacy And Safety Of Once-weekly GLP-1RA Versus Daily GLP-1RA For Type 2 Diabetes Mellitus:A Meta-analysis
29.
Effects Of Glucagon-like Peptide-1 Receptor Agonists On The Risk Of Blood Pressure In Patients With Type 2 Diabetes:A Systematic Review
30.
Cardiovascular Outcomes With Glucagon-like Peptide-1 Receptor Agonists In Patients With Type 2 Diabetes:A Meta-analysis
31.
Study On The Mechanism Of GLP-1R Nuclear Localization In Rat Aortic Vascular Smooth Muscle Cells
32.
Effects Of GLP-1RA On Rats With Type 2 Diabetes Mellitus And Nonalcoholic Fatty Liver Disease
33.
A Meta-Analysis Of The Efficacy And Safety Of Subcutaneous Injection Of Exenatide Once Weekly In The Treatment Of Type 2 Diabetes Mellitus
34.
Application Of A Novel Glucagon-like Peptide-1 Receptor Probe In PET Imaging Of Pheochromocytoma
35.
The Metabolic Profile Of Overweight/obese Type 2 Diabetic Patients And The Effect Of Glucagon-like Peptide-1 Receptor Agonist On Patients' Metabolic Indicators
36.
Glucagon-like Peptide-1 Receptor Pathway Inhibits Extracellular Matrix Production By Mesangial Cells Through Store-operated Ca
2+
Channel
37.
The Efficacy And Safety Of Exenatide In Patients With Diabetic Kidney Disease
38.
A Meta-analysis Of Glucagon-like Peptide-1 Receptor Agonists In Adults With Non-alcoholic Fatty Liver Disease
39.
Glucagon-like Peptide-1 Receptor Agonists And Pancreatitis And/or Pancreatic Cancer Risk In T2DM:a Systemic Review And Meta-analysis
40.
Effects Of GLP1R Gene Polymorphism On The Efficacy And Adverse Reactions Of GLP-1 Receptor Agonists In Chinese Patients With Type 2 Diabetes Mellitus
<<First
<Prev
Next>
Last>>
Jump to